By CTIBiotech
With our own published evidence and more than 30 years experience, we have optimized advanced cancer biopsy collection, cellular production and full 3D modelling in cancer. Having already partnered with oncology innovators, we have single cell, groups, cancer organoids and even 3D printed short-term and long-term screening systems that allow testing of chemotherapy combinations and dose, as well as state of the art new therapies. We collaborate globally with cancer innovators at cancer centers, hospitals, universities and companies, publishing regularly and bringing new screening systems to allow for personalized cancer treatments.
